Tag: Oncolytics Biotech

PNC Stock
Stock

Navigating ONCY Stock: Oncolytics Biotech, Inc Journey

The stock price for Oncolytics Biotech, Inc (ONCY) currently stands at $0.88. The stock experienced a substantial increase in the last session, hitting $5.01 after starting at $0.88. The stock’s lowest price was $3.05 before closing at $0.99. In terms of market performance, Oncolytics Biotech,

Industry

Oncolytics Biotech, Inc (ONCY) Stock: Navigating Drops and Gains

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Oncolytics Biotech, Inc’s current trading price is -33.76% away from its 52-week high, while its distance from the 52-week low is 211.08%. The stock’s

Finance

Oncolytics Biotech, Inc (ONCY) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Oncolytics Biotech, Inc’s current trading price is -22.22% away from its 52-week high, while its distance from the 52-week low is 265.25%.

Finance

Oncolytics Biotech, Inc (ONCY) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Oncolytics Biotech, Inc’s current trading price is -18.30% away from its 52-week high, while its distance from the 52-week low is 283.67%. The stock’s

Industry

ONCY’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease

CROX
Stock

ONCY’s Stock Market Pendulum: Swinging Between Gains and Losses

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -51.32%.However, over the last six months, we can see a stronger performance of -49.57%. Over

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.